In adults following MI, therapeutic deletion of pyruvate dehydrogenase kinase 4 (PDK4) increased glucose oxidation which induced cardiomyocyte mitosis, and attenuated adverse cardiac structure and function. Here, PDK4 is linked to myocardial infarction.